Search Results

Lone Star Bio

RadiaDyne Selected for the 2018 Start in France - Young Enterprise initiative International Immersion Program

RadiaDyne® was recently selected for the distinguished 2018 Start in France - Young Enterprise initiative.

August 7, 2018

·

2 min read

Job Trends

RadiaDyne’s OARtrac Technology Named To R&D 100 Award Finalists List

RadiaDyne®, the innovator of real-time, in vivo, diagnostic radiation patient dose monitoring technology for cancer treatment, and the exclusive manufacturer of the OARtrac® radiation dose monitoring system, was honored to be selected as a finalist for the 55th Annual R&D award.

August 23, 2018

·

2 min read

FDA

RadiaDyne Snags Clearance for Two Additional FDA Indications for the OARtrac System

RadiaDyne announces it received notice of additional FDA clearance for two new Indications of Use for their upcoming OARtrac radiation dose monitoring platform.

October 25, 2017

·

2 min read

Lone Star Bio

RadiaDyne Receives Skin Device Patent for the OARtrac Patient Radiation Dose Monitoring System

RadiaDyne announces issuance of US Patent 9,833,637, a skin patch dosimeter, which relates to the monitoring of skin radiation dose delivered during cancer treatment.

January 5, 2018

·

1 min read

Lone Star Bio

RadiaDyne Announces The Sale Of Their OARtrac Patient Dose Monitoring System To University Hospital’s Cleveland Medical Center (UH), Located In Cleveland, Ohio

RadiaDyne announces milestone commercial sale of their OARtrac system, a transformational diagnostic patient dose monitoring platform to one of the leaders in cancer treatment, University Hospital’s Cleveland Medical Center (UH), located in Cleveland, Ohio.

March 22, 2018

·

2 min read

Lone Star Bio

RadiaDyne Announces Recently Published Clinical Article Studying Proton Therapy for Post-Prostatectomy Cancer Patients Utilizing Their Market Leading Endorectal Balloon to Demonstrate Favorable Acute and Late GU and GI Toxicity Profiles

RadiaDyne, the designer and manufacturer of the market leading Endorectal Balloon device utilized during radiation therapy for prostate cancer, announced today a pivotal published study utilizing their technology.

July 31, 2018

·

2 min read

Deals

AngioDynamics to Acquire RadiaDyne and its Revolutionary OARtrac® Radiation Dose Monitoring Platform to Further Expand Oncology Portfolio

This transaction expands AngioDynamics’ growing Oncology business

September 13, 2018

·

5 min read

Lone Star Bio

RadiaDyne Announces First Commercial Sale Milestone of Their OARtrac Patient Dose Monitoring System to Leading Cancer Center

OARtrac provides critical radiation dose feedback which helps facilitate adaptive radiotherapy for true personalized treatment with the goal to reduce side effects and offer better clinical outcomes.

January 30, 2018

·

1 min read

Business

Med Venture Holdings Announces New CEO Appointment For Nimbus

The Managing Partners of Med Venture Holdings are pleased to announce the appointment of Bret Boudousquie as the new CEO of Nimbus®.

August 8, 2019

·

2 min read

Business

AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results

AngioDynamics, Inc.AngioDynamics, Inc.AngioDynamics, Inc.AngioDynamics, Inc., a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, announced financial results for the fourth quarter and fiscal year 2021, which ended May 31, 2021.

July 13, 2021

·

19 min read